Sinus Dilation Devices Market – Increasing demand of chronic sinusitis by manufacturers is expected to boost growth of the market
Sinus Dilation Devices Market – Increasing demand of chronic sinusitis by manufacturers is expected to boost growth of the market
Published by Coherent Market Insights
Posted on September 28, 2021
Sinusitis is a sinus inflammation that blocks the nose and prevents mucus drainage. Sinus dilation systems are used to extend sinus openings in patients with nose drainage problems associated with nasal sinusitis or sinuses. Different types of sinus dilation devices, such as functional endoscopic sinus surgery (FESS), sinus stents, rhinoscopes, and balloon sinuplasty systems, can be utilized for patients according to the need of the treatment.
Key Players Profiled in the Sinus Dilation Devices MarketReport are as follows: Entellus Medical, Inc., Smith & Nephew Plc., Acclarent, Inc., B. Braun Melsungen AG, Medtronic Plc, Olympus Corporation, SinuSys Corporation, InnAccel Technologies, and Intersect ENT, Inc.
Increasing demand for sinus dilation devices is expected to augment the growth of the global sinus dilation devices market over the forecast period. For instance, in January 2014, Acclarent, Inc. announced the U.S. launch of the Relieva Spin Balloon Sinuplasty System with the M-110C Sinus Guide Catheter Tip designed for the treatment of chronic sinusitis in children.
Moreover, in June 2015, SinuSys Corp. announced receipt of the CE Mark for two new devices that will expand the company’s portfolio of low-pressure, self-expanding dilation devices to treat frontal and sphenoid sinusitis, in addition to maxillary disease.
Furthermore, market players are adopting various strategies, such as mergers and acquisitions, to strengthen their market position, driving the growth of the global sinus dilation devices market. For instance, in February 2018, Stryker Corporation announced the completion of its previously announced acquisition of Entellus Medical.
Sinusitis is a sinus inflammation that blocks the nose and prevents mucus drainage. Sinus dilation systems are used to extend sinus openings in patients with nose drainage problems associated with nasal sinusitis or sinuses. Different types of sinus dilation devices, such as functional endoscopic sinus surgery (FESS), sinus stents, rhinoscopes, and balloon sinuplasty systems, can be utilized for patients according to the need of the treatment.
Key Players Profiled in the Sinus Dilation Devices MarketReport are as follows: Entellus Medical, Inc., Smith & Nephew Plc., Acclarent, Inc., B. Braun Melsungen AG, Medtronic Plc, Olympus Corporation, SinuSys Corporation, InnAccel Technologies, and Intersect ENT, Inc.
Increasing demand for sinus dilation devices is expected to augment the growth of the global sinus dilation devices market over the forecast period. For instance, in January 2014, Acclarent, Inc. announced the U.S. launch of the Relieva Spin Balloon Sinuplasty System with the M-110C Sinus Guide Catheter Tip designed for the treatment of chronic sinusitis in children.
Moreover, in June 2015, SinuSys Corp. announced receipt of the CE Mark for two new devices that will expand the company’s portfolio of low-pressure, self-expanding dilation devices to treat frontal and sphenoid sinusitis, in addition to maxillary disease.
Furthermore, market players are adopting various strategies, such as mergers and acquisitions, to strengthen their market position, driving the growth of the global sinus dilation devices market. For instance, in February 2018, Stryker Corporation announced the completion of its previously announced acquisition of Entellus Medical.